Rare complications with intravenous hyperosmotic alimentation
Clicks: 330
ID: 112945
1970
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
330 views
50 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #66 of 149 articles by views in JAMA
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 149 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Rare complications with intravenous hyperosmotic alimentation
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (6 words).
Try re-searching for a better abstract.
| Reference Key |
wj1970jamarare
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wyrick WJ;Rea WJ;McClelland RN;; |
| Journal | JAMA |
| Year | 1970 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
middle aged
carcinoma
pmid:4984270
w j wyrick
w j rea
r n mcclelland
squamous cell / surgery
coma / chemically induced
drug hypersensitivity / etiology
erythema / etiology
esophageal neoplasms / surgery
hypertonic solutions*
intestinal fistula / complications
osmosis
parenteral nutrition / adverse effects*
postoperative care
postoperative complications
uterine cervical neoplasms / surgery
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.